http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4080447-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_443d491bc96b073f9a30d903320015e1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-625
filingDate 1976-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1978-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5c3a67e48bbb6c3110a06da2122e223
publicationDate 1978-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4080447-A
titleOfInvention Therapeutic composition having an inhibiting activity on blood plate aggregation
abstract This invention relates to a therapeutic composition comprising, as active ingredient, a combination of 5-(2-chloro-benzyl)-4,5,6,7-tetrahydro-thieno[3,2-c]-pyridine and acetylsalicylic acid, the components of the combination being both present in the free state or as a pharmacologically acceptable salt. Said composition is useful both preventively and curatively for the treatment of thrombo-embolic diseases.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112336720-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8404703-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4357330-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004024013-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5401730-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-715655-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3228402-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1350511-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8569325-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007010499-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-297570-B6
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008108589-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4444777-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112336720-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6043368-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1350511-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0555042-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5382577-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011036533-A1
priorityDate 1975-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451466660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405496
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527521
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412544
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID657310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450990084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395791
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396248
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128918298
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129509037
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54404402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224

Total number of triples: 58.